Bryan is a 25-year veteran of the pharma and life science industry; specializing in product strategy, deal services, and R&D productivity. Deal, transformation and operations experience includes but is not limited to, pharmaceutical services and related AI technologies, companies/assets across small and large molecule pharmaceuticals, combination products, minimally invasive surgical devices, clinical diagnostics, life science research tools, generic pharmaceuticals and medical imaging.
A 2020 PM360 ELITE Strategist Award recipient, Bryan has held advisory and senior leadership roles at Abbott Laboratories, PwC, IQVIA, Syneos Health, KCR and ProPharma Group, where he currently serves as Chief Strategy Officer and Head of Corporate Development.
After serving in the United States Marine Corps, Bryan received his Master of Business Administration from the Kellogg School of Management at Northwestern University. Bryan also earned a Bachelor of Science in chemical engineering from Northwestern, where he specialized in process dynamics and controls.